Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Panbela Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | Security Type | | Security Class Title | | Fee Calculation Rule | | Amount Registered | | Proposed Maximum Offering Price Per Unit | | Maximum Aggregate Offering Price
(1) | | Fee Rate | | Amount of Registration Fee |
Fees to be Paid | Equity | | Common stock, $0.001 par value per share(2) | | Rule 457(o) | | | | | | $3,000,000(3) | | 0.00011020 | | $331 |
| | Equity | | Class A common stock purchase warrants(4)© | | Other | | | | | | | | | | |
| | Equity | | Common stock, $0.001 par value per share, underlying Class A common stock purchase warrants | | Rule 457(o) | | | | | | $3,000,000 | | 0.00011020 | | $331 |
| | Equity | | Class B common stock purchase warrants(7) | | Other | | | | | | | | | | |
| | Equity | | Common stock, $0.001 par value per share, underlying Class B common stock purchase warrants | | Rule 457(o) | | | | | | $18,000,000 | | 0.00011020 | | $1,984 |
Fees Previously Paid | Equity | | Common stock, $0.001 par value per share(2) | | Rule 457(o) | | | | | | $15,000,000(3) | | 0.00011020 | | $1,653 |
| | Equity | | Class A common stock purchase warrants(4) | | Other | | | | | | | | | | |
| | Equity | | Common stock, $0.001 par value per share, underlying Class A common stock purchase warrants | | Rule 457(o) | | | | | | $15,000,000 | | 0.00011020 | | $1,653 |
| | Equity | | Pre-funded warrants(4) | | Other | | | | | | | | | | |
| | Equity | | Common stock, $0.001 par value per share, underlying pre-funded warrants | | Rule 457(o) | | | | | | –(3) | | 0.00011020 | | – |
| | Total Offering Amounts | | | | | | $54,000,000 | | | | $5,952 |
| | Total Fees Previously Paid | | | | | | | | | | 3,306 |
| | Total Fee Offsets | | | | | | | | | | – |
| | Net Fee Due | | | | | | | | | | $2,646 |
(1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) of the Securities Act of 1933, as amended (the “Securities Act”). |
(2) | Pursuant to Rule 416 under the Securities Act, the shares of common stock registered hereby also include an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock split, stock dividends, recapitalizations, or other similar transactions. |
(3) | The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock, common warrants and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $18,000,000. |
(4) | No fee pursuant to Rule 457(g) of the Securities Act. |
